3-184711345-ATCCTCCTCCTCC-ATCCTCCTCCTCCTCCTCC
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_022149.5(MAGEF1):c.471_476dupGGAGGA(p.Glu157_Glu158dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00226 in 1,567,536 control chromosomes in the GnomAD database, including 36 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0085 ( 12 hom., cov: 0)
Exomes 𝑓: 0.0016 ( 24 hom. )
Consequence
MAGEF1
NM_022149.5 disruptive_inframe_insertion
NM_022149.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.156
Genes affected
MAGEF1 (HGNC:29639): (MAGE family member F1) This intronless gene encodes a member of the MAGE superfamily. It is ubiquitously expressed in normal tissues and in tumor cells. This gene includes a microsatellite repeat in the coding region. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 3-184711345-A-ATCCTCC is Benign according to our data. Variant chr3-184711345-A-ATCCTCC is described in ClinVar as [Benign]. Clinvar id is 403067.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00855 (1287/150552) while in subpopulation AFR AF= 0.0277 (1135/40980). AF 95% confidence interval is 0.0264. There are 12 homozygotes in gnomad4. There are 609 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEF1 | NM_022149.5 | c.471_476dupGGAGGA | p.Glu157_Glu158dup | disruptive_inframe_insertion | 1/1 | ENST00000317897.5 | NP_071432.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEF1 | ENST00000317897.5 | c.471_476dupGGAGGA | p.Glu157_Glu158dup | disruptive_inframe_insertion | 1/1 | 6 | NM_022149.5 | ENSP00000315064.3 |
Frequencies
GnomAD3 genomes AF: 0.00853 AC: 1283AN: 150432Hom.: 12 Cov.: 0
GnomAD3 genomes
AF:
AC:
1283
AN:
150432
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00301 AC: 730AN: 242436Hom.: 7 AF XY: 0.00243 AC XY: 319AN XY: 131400
GnomAD3 exomes
AF:
AC:
730
AN:
242436
Hom.:
AF XY:
AC XY:
319
AN XY:
131400
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00159 AC: 2257AN: 1416984Hom.: 24 Cov.: 88 AF XY: 0.00147 AC XY: 1035AN XY: 705666
GnomAD4 exome
AF:
AC:
2257
AN:
1416984
Hom.:
Cov.:
88
AF XY:
AC XY:
1035
AN XY:
705666
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00855 AC: 1287AN: 150552Hom.: 12 Cov.: 0 AF XY: 0.00828 AC XY: 609AN XY: 73526
GnomAD4 genome
AF:
AC:
1287
AN:
150552
Hom.:
Cov.:
0
AF XY:
AC XY:
609
AN XY:
73526
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at